Evidence map›Paper›PMID 36718192›Full record

ArticleInternational journal of nanomedicine2023

Incorporation of Targeting Biomolecule Improves Interpolymer Complex-Superparamagnetic Iron Oxide Nanoparticles Attachment to and Activation of T

Chukwuazam Nwasike, Erin Purr, Jaspreet Singh Nagi, Gretchen J Mahler, Amber L Doiron

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chukwuazam NwasikeDepartment of Biomedical Engineering, Binghamton University (SUNY), Binghamton, NY, USA.
Erin PurrDepartment of Biomedical Engineering, Binghamton University (SUNY), Binghamton, NY, USA.
Jaspreet Singh NagiDepartment of Electrical and Biomedical Engineering, University of Vermont, Burlington, VT, USA.
Gretchen J MahlerDepartment of Biomedical Engineering, Binghamton University (SUNY), Binghamton, NY, USA.
Amber L DoironDepartment of Electrical and Biomedical Engineering, University of Vermont, Burlington, VT, USA.ORCID 0000-0002-6963-0989
Binghamton University · USUniversity of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Inflammatory diseases are the leading cause of death in the world, accounting for 3 out of 5 deaths. Despite the abundance of diagnostic tools for detection, most screening and diagnostic methods are indirect and insufficient as they are unable to reliably discriminate between high-risk or low-risk stages of inflammatory diseases. Previously, we showed that the selective activation of interpolymer complexed superparamagnetic iron oxide nanoparticles (IPC-SPIOs) under oxidative conditions can be detected by a change in T Methods: Uncoated SPIOs were synthesized via coprecipitation from a mixture of FeCl Results and Discussion: Surface modification resulted in a slight reduction in ROS scavenging capacity; however, nanoparticle uptake by M2 macrophages increased by over 50%. The higher uptake did not cause a reduction in cellular viability. In fact, mannose-IPC-SPIOs induced significant T

Indexed as

Contrast MediaNanoparticlesFerric CompoundsMacrophagesMagnetic Iron Oxide NanoparticlesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMannoseReactive Oxygen SpeciesWaterContrast MediaFerric Compoundsferric oxideMannoseReactive Oxygen SpeciesWatercontrast agentsinflammatory diseasesmannose biomoleculesMRItargeted nanoparticles

Identifiers

PMID36718192
PMCPMC9884053
OpenAlexW4317773471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.